Dimension Therapeutics Inc (DMTX) - Financial and Strategic SWOT Analysis Review

  • ID: 4284641
  • SWOT Analysis
  • 47 pages
  • GlobalData
  • Dimension Therapeutics
1 of 5

FEATURED COMPANIES

  • Audentes Therapeutics Inc
  • GenSight Biologics SA
  • Spark Therapeutics Inc
  • Voyager Therapeutics
  • MORE
Dimension Therapeutics Inc (DMTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Dimension Therapeutics Inc (Dimension Therapeutics) is a developer of therapeutic products for the treatment of rare diseases associated with liver and genetic mutations. The company develops its product pipeline based on its mammalian adeno-associated virus gene delivery technology. Its products under development are intended for the treatment of inherited metabolic diseases including ornithine transcarbamylase deficiency, glycogen storage disease type Ia (GSDIa), citrullinemia type 1, PKU, wilson disease and hemophilia. The company also develops and commercialize product candidates for the treatment of hemophilia A. Dimension Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Dimension Therapeutics Inc Key Recent Developments

Aug 08,2017: Dimension Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Jul 24,2017: Dimension Therapeutics Announces Management Change
Jun 27,2017: Dimension Therapeutics Completes Strategic Review and Updates Corporate Priorities
May 10,2017: Dimension Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
Mar 09,2017: Dimension Therapeutics Announces Full Year 2016 Financial Results and Recent Updates Across Rare and Metabolic Disease Portfolio and in HeLa Manufacturing

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Audentes Therapeutics Inc
  • GenSight Biologics SA
  • Spark Therapeutics Inc
  • Voyager Therapeutics
  • MORE
Section 1 - About the Company
  • Dimension Therapeutics Inc - Key Facts
  • Dimension Therapeutics Inc - Key Employees
  • Dimension Therapeutics Inc - Key Employee Biographies
  • Dimension Therapeutics Inc - Major Products and Services
  • Dimension Therapeutics Inc - History
  • Dimension Therapeutics Inc - Company Statement
  • Dimension Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Dimension Therapeutics Inc - Business Description
  • Dimension Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Dimension Therapeutics Inc - Strengths
  • Dimension Therapeutics Inc - Weaknesses
  • Dimension Therapeutics Inc - Opportunities
  • Dimension Therapeutics Inc - Threats
  • Dimension Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Dimension Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 08, 2017: Dimension Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
  • Jul 24, 2017: Dimension Therapeutics Announces Management Change
  • Jun 27, 2017: Dimension Therapeutics Completes Strategic Review and Updates Corporate Priorities
  • May 10, 2017: Dimension Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
  • Mar 09, 2017: Dimension Therapeutics Announces Full Year 2016 Financial Results and Recent Updates Across Rare and Metabolic Disease Portfolio and in HeLa Manufacturing
  • Feb 07, 2017: Dimension Therapeutics Elects Dr. John A. Hohneker to Its Board of Directors
  • Dec 30, 2016: Gene therapy for liver disease advancing with the help of adeno-associated viral vectors
  • Nov 10, 2016: Dimension Therapeutics Reports Recent Corporate Progress and Third Quarter 2016 Financial Results
  • Nov 03, 2016: Dimension Therapeutics Announces Presentation at the Upcoming 58th American Society of Hematology (ASH) Annual Meeting
  • Oct 18, 2016: Dimension Therapeutics Announces Presentations Highlighting Advances in AAV Manufacturing at the European Society of Gene and Cell Therapy (ESGCT) Congress
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Dimension Therapeutics Inc, Key Facts
  • Dimension Therapeutics Inc, Key Employees
  • Dimension Therapeutics Inc, Key Employee Biographies
  • Dimension Therapeutics Inc, Major Products and Services
  • Dimension Therapeutics Inc, History
  • Dimension Therapeutics Inc, Subsidiaries
  • Dimension Therapeutics Inc, Key Competitors
  • Dimension Therapeutics Inc, Ratios based on current share price
  • Dimension Therapeutics Inc, Annual Ratios
  • Dimension Therapeutics Inc, Annual Ratios (Cont...1)
  • Dimension Therapeutics Inc, Interim Ratios
  • Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Dimension Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Dimension Therapeutics Inc, Performance Chart (2013 - 2016)
  • Dimension Therapeutics Inc, Ratio Charts
  • Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Voyager Therapeutics
  • Spark Therapeutics Inc
  • GenSight Biologics SA
  • Audentes Therapeutics Inc
  • Asklepios BioPharmaceutical Inc
  • Applied Genetic Technologies Corp
  • Adverum Biotechnologies Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll